Roche Invests $2.4 Billion in Autonomous AI Lab with 80% Phase III Success Rate

This investment highlights AI’s transformative potential in accelerating drug discovery and enhancing clinical trial efficacy.

Auto-scored: The event signifies a major beneficial development in medical AI with significant investment and improved scientific outcomes.